On Aug. 24, just a couple of days before her first day of school this fall, Sophia, a seventh grader at Ellsworth ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...